PRISM MarketView

PRISM Analysis: Why is Independence Contract Drilling Trading Up Today?

New York, January 30, 2024 - PRISM MarketView - Independence Contract Drilling, Inc. (NYSE: ICD) is trading up more than 5.0% in intraday trading on Tuesday, reaching a share price of $2.25. The drilling company is leading the PRISM MarketView Emerging Oil & Gas Inde...

30 January 2024

Vertex Pharmaceuticals Offers Hope with Non-Addictive Acute Pain Management

New York, January 30, 2024 - PRISM MarketView - Vertex Pharmaceuticals (Nasdaq: VRTX) is offering hope to the 80 million Americans suffering with acute pain each year with a non-addictive pain management alternative. Today, the company announced positive results from its...

30 January 2024

PRISM Market Momentum: Stocks on the Move on Tuesday; Gold, Bitcoin and General Motors Gain, Calix Slumps

New York, January 30, 2024 - PRISM MarketView - US equities are trading mostly lower on Tuesday at midday after finishing higher on Monday. Big tech is mixed, while autos, MedTech, and large-cap banks are outperforming. It’s a slower day for logistics, chemicals, buildin...

30 January 2024

GM reports Q4 sales and profit beat, issues improved profit outlook but admits EV pace has slowed

New York, January 30, 2024 - PRISM MarketView - General Motors (GM) disclosed a 54% drop in its Q4 pretax profits to $1.8 billion this Tuesday morning. Despite this, CEO Mary Barra remains confident about the future, particularly concerning their EV business. She express...

30 January 2024

AI-Powered Revolution: Taboola Transforms Digital Advertising, Surging Conversions for Global Brands in Just 3 Months

New York, January 30, 2024 - PRISM MarketView - Included in the PRISM Emerging AdTech and Media Index, Taboola (Nasdaq: TBLA) recently reported rapid adoption and positive results for its Maximize Conversions technology, a performance advertising-focused bidding system. ...

30 January 2024

Essa Pharma Soars on Clinical Update for Prostate Cancer Treatment

New York, January 30, 2024 - PRISM MarketView - Clinical stage pharmaceutical company, Essa Pharma (Nasdaq: EPIX), has presented updated dose escalation data from its Phase 1/2 study evaluating masofaniten in combination with enzalutamide for the treatment of prostate ca...

30 January 2024

Stocks making the biggest moves premarket: UPS, General Motors, Whirlpool, Spotify and more

New York, January 30, 2024 - PRISM MarketView - Here are the top companies that have made major moves before the market opens.

30 January 2024

Nexalin Awarded Key Patent for Deep Brain Stimulation Device

New York, January 29, 2024 - PRISM MarketView - Nexalin Technology (Nasdaq: NXL) has been awarded a key patent relating to the company’s non-invasive, frequency-based deep brain stimulation device by the United States Patent and Trademark Office (USPTO).

29 January 2024

PRISM Market Momentum: Stocks on the Move on Monday; Big Tech Higher, iRobot Falls as Amazon Acquisition Deal Crumbles

New York, January 29, 2024 - PRISM MarketView - US equities mostly higher overall on Monday at midday, in choppy trading. Stocks finished higher last week with the small-cap Russell posting solid gains after a four-week streak of declines. Big tech is mostly higher and s...

29 January 2024

Palisade Bio Presents Positive Preclinical Dates; Shares Rise 100%

New York, January 29, 2024 - PRISM MarketView - Shares in Palisade Bio (Nasdaq: PALI) rose by more than 100% in intraday trading on Monday after the company announced positive preclinical data from a study of its lead asset, PALI-2108 as a treatment for moderate-to-sever...

29 January 2024